Axon Enterprise, Inc.
AXONAxon beats Q2 2026 estimates with EPS $1.88, 35% revenue growth to $904M, raises 2026 revenue outlook to 32%–34%
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.08B | $1.56B | $1.19B | $863.38M | $681.00M | $530.86M | $420.07M | $343.80M |
| Cost of Revenue | $841.15M | $605.25M | $461.30M | $332.30M | $264.67M | $223.57M | $161.49M | $136.71M |
| Gross Profit | $1.24B | $955.45M | $728.64M | $531.09M | $416.33M | $307.29M | $258.58M | $207.09M |
| Gross Margin | 59.61% | 61.22% | 61.23% | 61.51% | 61.13% | 57.88% | 61.56% | 60.24% |
| Operating Expenses | $1.18B | $796.00M | $635.38M | $697.91M | $430.48M | $312.38M | $231.74M | $194.06M |
| Operating Income | $58.54M | $159.45M | $93.25M | $-166.82M | $-14.15M | $-5.09M | $26.84M | $13.02M |
| Operating Margin | 2.81% | 10.22% | 7.84% | -19.32% | -2.08% | -0.96% | 6.39% | 3.79% |
| Net Income | $377.03M | $175.78M | $147.14M | $-60.02M | $-1.72M | $882.00K | $29.20M | $5.21M |
| Net Margin | 18.10% | 11.26% | 12.37% | -6.95% | -0.25% | 0.17% | 6.95% | 1.51% |
| EPS (Basic) | $4.98 | $2.37 | $2.07 | $-0.91 | $-0.03 | $0.01 | $0.52 | $0.10 |
| EBITDA | $437.03M | $183.37M | $227.62M | $-117.11M | $6.28M | $13.43M | $38.72M | $23.80M |
| Stock Option Compensation Expense | $382.60M | $131.36M | $106.18M | $303.33M | $133.57M | $78.50M | $21.88M | $15.61M |
| Price To Earnings Ratio | 119.40 | 109.04 | 80.17 | -173.15 | -4391.04 | 4917.74 | 84.48 | 268.34 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $45.02B | $19.17B | $11.80B | $10.39B | $7.57B | $4.34B | $2.47B | $1.40B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $4.47B | $3.41B | $2.85B | $1.69B | $1.38B | $845.64M | $719.54M | $338.11M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.15B | $1.79B | $1.58B | $640.36M | $404.77M | $302.14M | $252.22M | $170.67M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $2.33B | $1.61B | $1.27B | $1.05B | $976.25M | $543.50M | $467.32M | $167.44M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.33B | $1.61B | $1.27B | $1.05B | $976.25M | $543.50M | $467.32M | $167.44M |
| Total Liabilities & Stockholders Equity | $4.47B | $3.41B | $2.85B | $1.69B | $1.38B | $845.64M | $719.54M | $338.11M |
| Book Value Per Share | $30.73 | $21.78 | $17.84 | $15.83 | $15.80 | $9.18 | $8.29 | $3.18 |
| Tangible Book Value Per Share | $18.43 | $20.73 | $17.04 | $14.94 | $15.24 | $8.54 | $7.56 | $2.54 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 8.43% | 5.16% | 5.16% | -3.56% | -0.12% | 0.10% | 4.06% | 1.54% |
| Return on Equity | 16.20% | 10.90% | 11.60% | -5.73% | -0.18% | 0.16% | 6.25% | 3.11% |
| Return on Invested Capital | 1.66% | 6.02% | 3.10% | -5.58% | -0.34% | -0.33% | 4.85% | 1.87% |
| Quick Ratio | 1.21 | 2.79 | 2.66 | 2.39 | 3.48 | 2.97 | 3.16 | 1.48 |
| Current Ratio | 1.37 | 3.14 | 3.00 | 2.65 | 3.83 | 3.17 | 3.36 | 1.90 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $377.03M | $175.78M | $147.14M | $-60.02M | $-1.72M | $882.00K | $29.20M | $5.21M |
| Depreciation | $48.42M | $19.32M | $31.11M | $24.27M | $12.47M | $11.36M | $10.62M | $8.04M |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $408.31M | $189.26M | $235.36M | $124.49M | $38.48M | $65.67M | $63.88M | $18.49M |
| Capital Expenditures | $78.78M | $59.63M | $56.11M | $50.28M | $72.87M | $16.34M | $11.70M | $11.44M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $0.00 | $0.00 | $74.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $329.53M | $128.99M | $179.25M | $74.22M | $-34.39M | $49.33M | $52.18M | $7.05M |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Show 12 more stories
Insider Trading
View AllCompany
About the company
Axon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software. These solutions are designed to equip law enforcement agencies with the means to capture, securely archive, manage, share, and analyze video and other digital evidence. Key products in this category include on-officer body cameras, Axon Fleet in-car systems, the Axon Evidence digital evidence management platform, Axon Signal-enabled devices, extended hardware warranties, and vital accessories like docks, cartridges, and batteries. Axon distributes its offerings through multiple channels, including its dedicated direct sales force, various distribution partners, its online storefront, and authorized third-party resellers. Furthermore, the company has established a strategic partnership with Fusus, Inc. to enhance the functionality of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution, providing agencies with real-time operational awareness and more efficient investigative processes.